Artery occlusion independently predicts unfavorable outcome in cervical artery dissection / Christopher Traenka, Caspar Grond-Ginsbach, Barbara Goeggel Simonetti, Tiina M. Metso, Stéphanie Debette, Alessandro Pezzini, Manja Kloss, Jennifer J. Majersik, Andrew M. Southerland, Didier Leys, Ralf Baumgartner, Valeria Caso, Yannick Béjot, Gian Marco De Marchis, Urs Fischer, Alexandros Polymeris, Hakan Sarikaya, Vincent Thijs, Bradford B. Worrall, Anna Bersano, Tobias Brandt, Henrik Gensicke, Leo H. Bonati, Emmanuel Touzeé, Juan J. Martin, Hugues Chabriat, Turgut Tatlisumak, Marcel Arnold, Stefan T. Engelter, Philippe Lyrer, for the CADISP-Plus Study Group
OBJECTIVE: To assess the impact of dissected artery occlusion (DAO) on functional outcome and complications in patients with cervical artery dissection (CeAD). - METHODS: We analyzed combined individual patient data from 3 multicenter cohorts of consecutive patients with CeAD (the Cervical Artery Dissection and Ischemic Stroke Patients [CADISP]-Plus consortium dataset). Patients with data on DAO and functional outcome were included. We compared patients with DAO to those without DAO. Primary outcome was favorable functional outcome (i.e., modified Rankin Scale [mRS] score 0-1) measured 3-6 months from baseline. Secondary outcomes included delayed cerebral ischemia, major hemorrhage, recurrent CeAD, and death. We performed univariate and multivariable binary logistic regression analyses and calculated odds ratios (OR) with 95% confidence intervals (CI), with adjustment for potential confounders. - RESULTS: Of 2,148 patients (median age 45 years [interquartile range (IQR) 38-52], 43.6% women), 728 (33.9%) had DAO. Patients with DAO more frequently presented with cerebral ischemia (84.6% vs 58.5%, p < 0.001). Patients with DAO were less likely to have favorable outcome when compared to patients without DAO (mRS 0-1: 59.6% vs 80.1%, punadjusted < 0.001). After adjustment for age, sex, and initial stroke severity, DAO was independently associated with less favorable outcome (mRS 0-1: OR 0.65, CI 0.50-0.84, p = 0.001). Delayed cerebral ischemia occurred more frequently in patients with DAO than in patients without DAO (4.5% vs 2.9%, p = 0.059). - CONCLUSION: DAO independently predicts less favorable functional outcome in patients with CeAD. Further research on vessel patency, collateral status and effects of revascularization therapies particularly in patients with DAO is warranted..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
---|---|
Enthalten in: |
Neurology - 94(2020), 2, Seite e170-e180 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tränka, Christopher, 1984- [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Adult |
---|
Anmerkungen: |
First published November 22, 2019 Gesehen am 29.06.2020 |
---|
Umfang: |
11 |
---|
doi: |
10.1212/WNL.0000000000008654 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1702887480 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1702887480 | ||
003 | DE-627 | ||
005 | 20230428073848.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200629r20202019xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1212/WNL.0000000000008654 |2 doi | |
035 | |a (DE-627)1702887480 | ||
035 | |a (DE-599)KXP1702887480 | ||
035 | |a (OCoLC)1341342068 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Tränka, Christopher |d 1984- |e verfasserin |0 (DE-588)1107026458 |0 (DE-627)863299474 |0 (DE-576)474965961 |4 aut | |
245 | 1 | 0 | |a Artery occlusion independently predicts unfavorable outcome in cervical artery dissection |c Christopher Traenka, Caspar Grond-Ginsbach, Barbara Goeggel Simonetti, Tiina M. Metso, Stéphanie Debette, Alessandro Pezzini, Manja Kloss, Jennifer J. Majersik, Andrew M. Southerland, Didier Leys, Ralf Baumgartner, Valeria Caso, Yannick Béjot, Gian Marco De Marchis, Urs Fischer, Alexandros Polymeris, Hakan Sarikaya, Vincent Thijs, Bradford B. Worrall, Anna Bersano, Tobias Brandt, Henrik Gensicke, Leo H. Bonati, Emmanuel Touzeé, Juan J. Martin, Hugues Chabriat, Turgut Tatlisumak, Marcel Arnold, Stefan T. Engelter, Philippe Lyrer, for the CADISP-Plus Study Group |
264 | 1 | |c 2020 | |
300 | |a 11 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a First published November 22, 2019 | ||
500 | |a Gesehen am 29.06.2020 | ||
520 | |a OBJECTIVE: To assess the impact of dissected artery occlusion (DAO) on functional outcome and complications in patients with cervical artery dissection (CeAD). - METHODS: We analyzed combined individual patient data from 3 multicenter cohorts of consecutive patients with CeAD (the Cervical Artery Dissection and Ischemic Stroke Patients [CADISP]-Plus consortium dataset). Patients with data on DAO and functional outcome were included. We compared patients with DAO to those without DAO. Primary outcome was favorable functional outcome (i.e., modified Rankin Scale [mRS] score 0-1) measured 3-6 months from baseline. Secondary outcomes included delayed cerebral ischemia, major hemorrhage, recurrent CeAD, and death. We performed univariate and multivariable binary logistic regression analyses and calculated odds ratios (OR) with 95% confidence intervals (CI), with adjustment for potential confounders. - RESULTS: Of 2,148 patients (median age 45 years [interquartile range (IQR) 38-52], 43.6% women), 728 (33.9%) had DAO. Patients with DAO more frequently presented with cerebral ischemia (84.6% vs 58.5%, p < 0.001). Patients with DAO were less likely to have favorable outcome when compared to patients without DAO (mRS 0-1: 59.6% vs 80.1%, punadjusted < 0.001). After adjustment for age, sex, and initial stroke severity, DAO was independently associated with less favorable outcome (mRS 0-1: OR 0.65, CI 0.50-0.84, p = 0.001). Delayed cerebral ischemia occurred more frequently in patients with DAO than in patients without DAO (4.5% vs 2.9%, p = 0.059). - CONCLUSION: DAO independently predicts less favorable functional outcome in patients with CeAD. Further research on vessel patency, collateral status and effects of revascularization therapies particularly in patients with DAO is warranted. | ||
534 | |c 2019 | ||
650 | 4 | |a Adult | |
650 | 4 | |a Aged | |
650 | 4 | |a Aneurysm, Dissecting | |
650 | 4 | |a Cerebral Arterial Diseases | |
650 | 4 | |a Cerebrovascular Disorders | |
650 | 4 | |a Female | |
650 | 4 | |a Humans | |
650 | 4 | |a Male | |
650 | 4 | |a Middle Aged | |
650 | 4 | |a Recovery of Function | |
700 | 1 | |a Grond-Ginsbach, Caspar |e verfasserin |0 (DE-588)1050235622 |0 (DE-627)783682522 |0 (DE-576)182813088 |4 aut | |
700 | 1 | |a Goeggel Simonetti, Barbara |e verfasserin |4 aut | |
700 | 1 | |a Metso, Tiina M. |e verfasserin |4 aut | |
700 | 1 | |a Debette, Stéphanie |e verfasserin |4 aut | |
700 | 1 | |a Pezzini, Alessandro |d 1959- |e verfasserin |0 (DE-588)140357734 |0 (DE-627)70364999X |0 (DE-576)316573744 |4 aut | |
700 | 1 | |a Kloss, Manja |d 1972- |e verfasserin |0 (DE-588)136117945 |0 (DE-627)694095788 |0 (DE-576)300842112 |4 aut | |
700 | 1 | |a Majersik, Jennifer J. |e verfasserin |4 aut | |
700 | 1 | |a Southerland, Andrew M. |e verfasserin |4 aut | |
700 | 1 | |a Leys, Didier |e verfasserin |4 aut | |
700 | 1 | |a Baumgartner, Ralf |e verfasserin |4 aut | |
700 | 1 | |a Caso, Valeria |e verfasserin |4 aut | |
700 | 1 | |a Béjot, Yannick |e verfasserin |4 aut | |
700 | 1 | |a De Marchis, Gian Marco |e verfasserin |4 aut | |
700 | 1 | |a Fischer, Urs |e verfasserin |4 aut | |
700 | 1 | |a Polymeris, Alexandros |e verfasserin |4 aut | |
700 | 1 | |a Sarikaya, Hakan |e verfasserin |4 aut | |
700 | 1 | |a Thijs, Vincent |e verfasserin |4 aut | |
700 | 1 | |a Worrall, Bradford B. |e verfasserin |4 aut | |
700 | 1 | |a Bersano, Anna |e verfasserin |4 aut | |
700 | 1 | |a Brandt, Tobias |e verfasserin |0 (DE-588)1064032869 |0 (DE-627)812888227 |0 (DE-576)423579487 |4 aut | |
700 | 1 | |a Gensicke, Henrik |e verfasserin |4 aut | |
700 | 1 | |a Bonati, Leo H. |e verfasserin |4 aut | |
700 | 1 | |a Touzeé, Emmanuel |e verfasserin |4 aut | |
700 | 1 | |a Martin, Juan J. |e verfasserin |4 aut | |
700 | 1 | |a Chabriat, Hugues |e verfasserin |4 aut | |
700 | 1 | |a Tatlisumak, Turgut |e verfasserin |4 aut | |
700 | 1 | |a Arnold, Marcel |e verfasserin |4 aut | |
700 | 1 | |a Engelter, Stefan T. |e verfasserin |4 aut | |
700 | 1 | |a Lyrer, Philippe |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurology |d Philadelphia, Pa. : Wolters Kluwer, 1951 |g 94(2020), 2, Seite e170-e180 |h Online-Ressource |w (DE-627)302718524 |w (DE-600)1491874-2 |w (DE-576)079876609 |x 1526-632X |7 nnns |
773 | 1 | 8 | |g volume:94 |g year:2020 |g number:2 |g pages:e170-e180 |g extent:11 |
856 | 4 | 0 | |u https://doi.org/10.1212/WNL.0000000000008654 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_374 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
936 | u | w | |d 94 |j 2020 |e 2 |h e170-e180 |g 11 |
951 | |a AR | ||
952 | |d 94 |j 2020 |e 2 |h e170-e180 |g 11 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 369217358X |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 29-06-20 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2020 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_30 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_11 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1474485146 |a Grond-Ginsbach, Caspar | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416740848 |a Chirurgische Universitätsklinik | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1474485448 |a Kloss, Manja | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_7 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1493580841 |a Brandt, Tobias | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_21 |